hSmad5 gene, a human hSmad family member:: its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors

被引:35
作者
Gemma, A
Hagiwara, K
Vincent, F
Ke, Y
Hancock, AR
Nagashima, M
Bennett, WP
Harris, CC [1 ]
机构
[1] NCI, Human Carcinogenesis Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA
[2] IFREMER, Lab Ecotoxicol, F-44311 Nantes 03, France
[3] Beijing Med Univ, Sch Oncol, Beijing 100034, Peoples R China
关键词
transforming growth factor-beta; cDNA; genomic structure; PCR-SSCP;
D O I
10.1038/sj.onc.1201614
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
hSmad (mothers against decapentaplegic)-related proteins are important messengers within the Transforming Growth Factor-beta(1) (TGF-beta(1)) superfamily signal transduction pathways. To further characterize a member of this family, we obtained a full length cDNA of the human hSmad5 (hSmad5) gene by rapid amplification of cDNA ends (RACE) and then determined the genomic structure of the gene. There are eight exons and two alternative transcripts; the shorter transcript lacks exon 2. We identified the hSmad5 promoter region from a human genomic YAC clone by obtaining the nucleotide sequence extending 1235 base pairs upstream of the 5' end of the cDNA. We found a CpG island consistent with a promoter region, and we demonstrated promoter activity in a 1232 bp fragment located upstream of the transcription initiation site. To investigate the frequency of somatic hSmad5 mutations in human cancers, we designed intron-based primers to examine coding regions by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis. Neither homozygous deletions or point mutations were found in 40 primary gastric tumors and 51 cell lines derived from diverse types of human cancer including 20 cell lines resistant to the growth inhibitory effects of TGF-beta(1). These results suggest that the hSmad5 gene is not commonly mutated and that other genetic alterations mediate the loss of TGF-beta(1) responsiveness in human cancers.
引用
收藏
页码:951 / 956
页数:6
相关论文
共 31 条
  • [1] TGF-BETA RECEPTORS AND ACTIONS
    ATTISANO, L
    WRANA, JL
    LOPEZCASILLAS, F
    MASSAGUE, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1222 (01): : 71 - 80
  • [2] A novel mesoderm inducer, Madr2 functions in the activin signal transduction pathway
    Baker, JC
    Harland, RM
    [J]. GENES & DEVELOPMENT, 1996, 10 (15) : 1880 - 1889
  • [3] FUNCTIONAL-ANALYSIS OF THE TRANSFORMING GROWTH-FACTOR-BETA RESPONSIVE ELEMENTS IN THE WAF1/CIP1/P21 PROMOTER
    DATTO, MB
    YU, Y
    WANG, XF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) : 28623 - 28628
  • [4] MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
    Eppert, K
    Scherer, SW
    Ozcelik, H
    Pirone, R
    Hoodless, P
    Kim, H
    Tsui, LC
    Bapat, B
    Gallinger, S
    Andrulis, IL
    Thomsen, GH
    Wrana, JL
    Attisano, L
    [J]. CELL, 1996, 86 (04) : 543 - 552
  • [5] CLONING OF A TGF-BETA TYPE-I RECEPTOR THAT FORMS A HETEROMERIC COMPLEX WITH THE TGF-BETA TYPE-II RECEPTOR
    FRANZEN, P
    TENDIJKE, P
    ICHIJO, H
    YAMASHITA, H
    SCHULZ, P
    HELDIN, CH
    MIYAZONO, K
    [J]. CELL, 1993, 75 (04) : 681 - 692
  • [6] FYNAN TM, 1993, CRIT REV ONCOGENESIS, V4, P493
  • [7] CPG ISLANDS IN VERTEBRATE GENOMES
    GARDINERGARDEN, M
    FROMMER, M
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1987, 196 (02) : 261 - 282
  • [8] Gemma A, 1997, CANCER RES, V57, P1435
  • [9] Gemma A, 1996, INT J CANCER, V68, P605, DOI 10.1002/(SICI)1097-0215(19961127)68:5<605::AID-IJC9>3.0.CO
  • [10] 2-2